These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 29541637)
61. A novel missense mutation in the factor XII gene in a litter of cats with factor XII deficiency. Maruyama H; Hosoe H; Nagamatsu K; Kano R; Kamata H J Vet Med Sci; 2017 May; 79(5):822-826. PubMed ID: 28392508 [TBL] [Abstract][Full Text] [Related]
62. Standardization of Factor VIII-IV. Establishment of the 3rd International Standard for Factor VIII: C concentrate. Barrowcliffe TW; Curtis AD; Thomas DP Thromb Haemost; 1983 Oct; 50(3):697-702. PubMed ID: 6417819 [TBL] [Abstract][Full Text] [Related]
63. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma. Heath AB; Barrowcliffe TW Thromb Haemost; 1992 Aug; 68(2):155-9. PubMed ID: 1412160 [TBL] [Abstract][Full Text] [Related]
64. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. Jones DW; Gallimore MJ; MacKie IJ; Harris SL; Winter M Br J Haematol; 2000 Sep; 110(3):721-6. PubMed ID: 10997986 [TBL] [Abstract][Full Text] [Related]
65. Factor XII determinations in the presence and absence of phospholipid antibodies. Gallimore MJ; Jones DW; Winter M Thromb Haemost; 1998 Jan; 79(1):87-90. PubMed ID: 9459329 [TBL] [Abstract][Full Text] [Related]
66. Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency. Ishii K; Oguchi S; Moriki T; Yatabe Y; Takeshita E; Murata M; Ikeda Y; Watanabe K Blood Coagul Fibrinolysis; 2004 Jul; 15(5):367-73. PubMed ID: 15205584 [TBL] [Abstract][Full Text] [Related]
67. The fourth International Standard for Human Urinary FSH and LH: specificities of LH seminal vesicle weight gain assays in the collaborative study differ between laboratories. Storring PL; Gaines Das RE J Endocrinol; 2001 Oct; 171(1):119-29. PubMed ID: 11572796 [TBL] [Abstract][Full Text] [Related]
68. Calibration of the second International Standard for hepatitis B immunoglobulin in an international collaborative study. Ferguson M; Yu MW; Heath A Vox Sang; 2010 Jul; 99(1):77-84. PubMed ID: 20202182 [TBL] [Abstract][Full Text] [Related]
69. Factor XII in coagulation, inflammation and beyond. Didiasova M; Wujak L; Schaefer L; Wygrecka M Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759 [TBL] [Abstract][Full Text] [Related]
70. The Effects of the Contact Activation System on Hemorrhage. Simão F; Feener EP Front Med (Lausanne); 2017; 4():121. PubMed ID: 28824910 [TBL] [Abstract][Full Text] [Related]
71. Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis. Kohs TCL; Lorentz CU; Johnson J; Puy C; Olson SR; Shatzel JJ; Gailani D; Hinds MT; Tucker EI; Gruber A; McCarty OJT; Wallisch M Cell Mol Bioeng; 2021 Apr; 14(2):161-175. PubMed ID: 33868498 [TBL] [Abstract][Full Text] [Related]
72. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes. Matata BM; Courtney JM; Sundaram S; Wark S; Bowry SK; Vienken J; Lowe GD J Biomed Mater Res; 1996 May; 31(1):63-70. PubMed ID: 8731150 [TBL] [Abstract][Full Text] [Related]
73. Competitive-protein adsorption in contact activation of blood factor XII. Zhuo R; Siedlecki CA; Vogler EA Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174 [TBL] [Abstract][Full Text] [Related]
74. Single-chain factor XII: a new form of activated factor XII. Ivanov I; Matafonov A; Gailani D Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413 [TBL] [Abstract][Full Text] [Related]
75. Autoantibodies to Factor XII and Kininogen-Dependent Antiphosphatidylethanolamine Antibodies in Patients with Recurrent Pregnancy Loss Augment Platelet Aggregation. Sato Y; Sugi T; Sakai R Am J Reprod Immunol; 2015 Sep; 74(3):279-89. PubMed ID: 26011374 [TBL] [Abstract][Full Text] [Related]
76. Standardisation of protein S in plasma: calibration of the 1st International Standard. Hubbard AR Thromb Haemost; 1997 Oct; 78(4):1237-41. PubMed ID: 9364991 [TBL] [Abstract][Full Text] [Related]
77. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein. Hoem NO; Johannesen S; Briseid K Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207 [TBL] [Abstract][Full Text] [Related]
79. The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation. Thorpe SJ; Heath A; Fox B; Patel D; Egner W Clin Chem Lab Med; 2014 Sep; 52(9):1283-9. PubMed ID: 24807170 [TBL] [Abstract][Full Text] [Related]
80. A novel factor XII mutation, FXII R84P, causing factor XII deficiency in a patient with hereditary spastic paraplegia. Matsuki E; Miyakawa Y; Okamoto S Blood Coagul Fibrinolysis; 2011 Apr; 22(3):227-30. PubMed ID: 21297451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]